Lisa Wilson | IR |
Scott Tarriff | CEO & Director |
Pete Meyers | CFO |
Ashley Ryu | RBC Capital Markets |
Brandon Folkes | Cantor Fitzgerald |
Good day, and welcome to today's program. My name is Keith, and I'll be your conference operator today. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals Second Quarter 2019 Earnings Results Conference Call.
[Operator Instructions].
As a reminder, this conference call is being recorded, August 8, 2019.